The Jacquot Awards support nephrologists wishing to establish or pursue a research career for the treatment and management of renal disease.

In 1985, Mrs Lorraine Jacquot of Trash and Treasure Australia Pty Ltd established the Don Jacquot Fellowship in memory of her late husband. Following her death in 1992, the RACP Foundation received an additional bequest from Lorraine and the Fellowship was renamed the Don and Lorraine Jacquot Fellowship. Their legacy has allowed for the funding of additional Fellowships and Scholarships over time.

The Awards are co-administered by the RACP and the Australian and New Zealand Society of Nephrology (ANZSN). Representatives from the ANSZN Research Advisory Committee and the RACP Grants Advisory Committees (GAC) assess all Jacquot Award applications.

We are all are grateful for the guidance and support of Ian and Zanette Brown and the Rowling family in the administration of these prestigious Awards.

Current recipients

Dr Jen Li is a staff specialist nephrologist and transplant physician at Westmead Hospital and senior clinical lecturer with the Westmead Clinical School.

She completed her PhD in 2023 and continues on as a post-doctoral researcher in the Centre for Transplant and Renal Research at the Westmead Institute for Medical Research. Jen is a member of both the Transplant Genomics Group and Kidney Injury Group and her research is focused on using precision medicine to advance kidney transplant outcomes.

2024 Jacquot Research Establishment Fellowship ($90,000)
Dr Prasanti Kotagiri
Autoreactive B cells in IgAN

Dr Prasanti Kotagiri is a Nephrologist and early career researcher with a strong interest in B cell immunology. On completion of her renal specialist training, she undertook a PhD at Cambridge University in Prof Ken Smith’s laboratory. Her work involved studying the immune cell transcriptome and B cell receptor repertoire in auto-immunity, infection and vaccination.

She is also a Fulbright Fellow where she worked in Prof Scott Boyd's laboratory analysing single cell BCR repertoire data to better understand vaccine responses. Since relocating to Melbourne she has been appointed as a Senior Lecturer in the Department of Immunology, Monash University. She is the recipient of a McKenzie Postdoctoral Fellowship and a Viertel Fellowship

2024 Jacquot Research Establishment Fellowship ($90,000)
Dr Emily See
Improving kidney outcomes for critically ill patients with vasodilatory shock through personalised vasopressor therapy

Dr Emily See is a critical care nephrologist and clinician-scientist at the Royal Melbourne Hospital. She holds a MSc in Medical Statistics from the University of Oxford and a PhD in Clinical Medicine from the University of Melbourne. Her interests centre around acute kidney injury, continuous renal replacement therapy, and the management of vasodilatory shock. She is recognised as an emerging international leader in critical care nephrology research and has an established track record of research program leadership.

This grant will allow Dr See to undertake pivotal work on the role of angiotensin II in the management of critically ill patients with vasodilatory shock. Through this research program, she will establish a set of core outcomes and outcome measures for acute kidney injury; evaluate prognostic and predictive biomarkers of renin-angiotensin system dysfunction and response to angiotensin II therapy; and investigate the feasibility, safety and efficacy of angiotensin II as the first-line vasopressor.

The findings of this work have the potential to fundamentally change the way vasodilatory shock is managed on a global scale, while focusing on impacting the outcomes prioritised by patients, caregivers, and clinicians.

2024 Jacquot Research Establishment Fellowship ($90,000)
A/Prof Amanda Ying Wang
Therapeutic Prevention for Acute Kidney Injury

A.Prof Amanda Ying Wang is a staff specialist nephrologist at Concord Repatriation General Hospital, Clinical Associate Professor at Macquarie University and Senior Research Fellow at George Institute for Global Health. She completed her clinical nephrology training in 2012 at Concord and Royal Prince Alfred Hospitals. After completion of a PhD in dialysis epidemiology at the University of Sydney, she was awarded the John Chalmers’ Servier post-doctoral fellowship in 2016 followed by National Heart Foundation Post-doctoral fellowship in 2018, Jacquot Research Establishment Fellowship and National Heart Foundation Vanguard Grant in 2021 to support her research on Acute Kidney Injury and dialysis therapy.

Amanda led the IMPROVE-AKI, DISCOVER, and PERFORM-AKI studies, and participated in a number of national and international RCTs such as the STARRT-AKI, ACHIEVE and TESTING studies. She has contributed to about 70 publications in peer-reviewed journals including publications in high impact journals such as the NEJM, JAMA Network Open and Nature Reviews Nephrology. She is an academic editor for PLOS One and Medicine Advances. Amanda is also a visiting professor at Beijing Friendship Hospital affiliated to Capital Medical University, China. She was awarded a high-level foreign expert by China Administration of Foreign Experts Affairs in 2019.

Dr Katharine Hegerty is a current PhD Student with the University of Queensland and is completing a clinical epidemiology PhD focussed on incremental haemodialysis, the haemodialysis consumer experience and the INCremental dialysis to improve Health outcomes for people starting Haemodialysis (INCH- HD) trial. She is also a kidney specialist working for the Kidney and Transplant Service at the Princess Alexandra Hospital in Brisbane, QLD. She is committed to ongoing development of clinician-researcher skills, education and mentoring within haemodialysis and transplant medicine. She also completes unscheduled night shift work with her 9-month-old daughter and husband.

Dr. Dana Kim is a nephrologist and PhD Candidate at the University of Sydney. She completed her clinical nephrology training across the East Coast Network of New South Wales and became a fellow of the RACP in January 2022 before embarking on her early research career. She is a Research Associate at The George Institute for Global Health where she is involved in large international clinical trials in kidney disease. Her interests lie in the early identification of individuals at risk of kidney failure and interventions aimed at slowing the progression of chronic kidney disease.

Dana's research on the effects of corticosteroid therapy in patients with IgA Nephropathy has received global recognition from the International Society of Nephrology and the International IgA Nephropathy Network. Her PhD also aims to leverage state-of-the-art MRI techniques established in cardiovascular disease to develop a safe non-invasive diagnostic tool to detect patients with early CKD at risk of advanced disease. Dana is passionate about advancing our understanding of kidney-related conditions and improving outcomes at both an individual patient level and broader global scale.

Dr Lachlan McMichael is a kidney specialist & early career clinician-researcher. He is a PhD candidate at the South Australian Health and Medical Research Institute and a research fellow at the University of British Columbia, Canada. His research program is focused on analysing international trends in wait-listing for kidney transplantation, developing administrative measures of eligibility for kidney transplantation in patients with kidney failure and assessing resource utilisation during evaluation for kidney transplantation.

Dr McMichael completed his medical degree at the University of Adelaide in 2013. He undertook Basic Physician Training at Central Adelaide Local Health Network and completed his Nephrology Advanced Training at the Central and Northern Adelaide Renal & Transplantation Service. He became a Fellow of the RACP in 2021.

Dr McMichael has completed clinical fellowships in Nephrology and Kidney Transplantation at the University of British Columbia, Vancouver, Canada between 2020-2022 and completed a Master of Medicine (Clinical Epidemiology) from the University of Sydney in 2022. Dr McMichael hopes his research will inform contemporary kidney transplant practice by reducing the current variation in approaches to kidney transplant evaluation and optimising resource utilisation.

2024 Jacquot Research Entry Scholarship ($45,000)
Dr Arushi Ramnarain
Treatment patterns and outcomes of patients with lupus nephritis

Dr Arushi Ramnarain is an early career nephrologist and PhD candidate affiliated with Monash Health. After studying medicine at The University of Adelaide, she undertook basic physician training in Melbourne. Thereafter, she completed nephrology advanced training at Monash Health, Eastern Health and The Royal Melbourne Hospital. In 2022 she was conferred her fellowship from the Royal Australasian College of Physicians.

Dr Ramnarain is presently pursuing a clinical PhD at Monash University studying lupus nephritis, a renal manifestation of systemic lupus erythematosus, which is associated with adverse outcomes. Her research aims to identify crucial patient, disease, and treatment-related factors affecting morbidity, with the ultimate goal of optimizing disease control, whilst minimizing complications and improving quality of life within this cohort of patients

Jacquot Selection Committee

Professor Robert Walker, Co-chair (ANZSN Research Advisory Committee)

A/Prof Tim Hewitson, Co-chair (ANZSN Research Advisory Committee)

Professor Graham Lieschke (Chair RACP Grants Advisory Committee)

Professor Andrew Mallett – Member (RACP Grants Advisory Committee)

Professor Stephen Alexander – Member, RACP

Professor Natasha Rogers – Member (ANZSN)

Dr Sih Min Tan – Member (ANZSN)

Dr Rathika Krishnasamy – Member (ANZSN)

Back to Research Award and Career Grants